Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Turn Therapeutics has reported Retained Earnings for 3 years, with the latest figure at -$23.4 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings changed N/A year-over-year to -$23.4 million; the trailing twelve-month figure through Mar 2026 stood at -$23.4 million (changed N/A YoY), and the FY2025 full-year result was -$22.4 million, down 16.64% from the prior year.
• Retained Earnings for Q1 2026 stood at -$23.4 million, down from -$22.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$19.2 million in Q4 2024, with the low at -$23.4 million in Q1 2026.
• Average Retained Earnings over 3 years is -$21.9 million, with a median of -$22.5 million recorded in 2025.
• Peak annual rise in Retained Earnings reached 16.64% in 2025, while the deepest fall reached 16.64% in 2025.
• Tracing TTRX's Retained Earnings over 3 years: stood at -$19.2 million in 2024, then dropped by 16.64% to -$22.4 million in 2025, then retreated by 4.34% to -$23.4 million in 2026.
• The last three Retained Earnings figures came in at -$23.4 million (Q1 2026), -$22.4 million (Q4 2025), and -$22.7 million (Q3 2025), per Business Quant data.

Peer Comparison